Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Revelation Biosciences, Inc.
Revelation Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 21, 2026
Revelation Biosciences Announces Adoption of Stockholder Rights Plan
July 10, 2026
Revelation Biosciences Expands Acute Kidney Injury Advisory Board
June 1, 2026
Revelation Biosciences, Inc. Releases Corporate Update Letter to Stockholders
May 25, 2026
Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board
May 20, 2026
Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study
May 19, 2026
Revelation Biosciences, Inc. Announces Financial Results For the Three Months Ended March 31, 2026
May 17, 2026
Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference
May 17, 2026
Revelation Biosciences Inc. Announces 1-for-4 Reverse Stock Split Effective January 28, 2026
January 26, 2026
Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds
January 23, 2026